Aspire Biopharma Holdings (ASBP) Revenue (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Revenue came in at $28353.0 in Q1 2026, up 565.41% on a QoQ basis from $4261.0 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Revenue (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of Revenue data on file, last reported at $28353.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 | 28,353.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,353.00 |
| Dec 31, 2025 | 4,261.00 |
| Sep 30, 2025 | 1,941.00 |